Sunday
June 22, 2025
4:00 PM ET
Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025
Wednesday
June 11, 2025
4:00 PM ET
Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025
Tuesday
June 10, 2025
1:00 AM ET
Molecular Partners Announces Planned Operational Efficiencies and Extension of Cash Runway
Thursday
May 15, 2025
4:00 PM ET
Molecular Partners Reports Financial Results and Highlights from Q1 2025
Friday
April 25, 2025
4:00 PM ET
Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025
Wednesday
April 16, 2025
12:00 PM ET
Molecular Partners Announces all Board Proposals Approved at Annual General Meeting
Tuesday
March 25, 2025
4:00 PM ET
Molecular Partners to hold three poster presentations at AACR 2025
Tuesday
March 25, 2025
12:00 PM ET
Molecular Partners Publishes Invitation to Annual General Meeting 2025
Thursday
March 6, 2025
4:00 PM ET
Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024
Friday
February 28, 2025
1:00 AM ET
Molecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference Call